Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are suspected of having, or have been diagnosed with, high blood pressure (hypertension)
- People between the ages of 40 and 75
- People who have had aldosterone and renin blood test results available during a one-day clinic visit (these are hormones that affect blood pressure)
- People who are already scheduled for a specific overnight hormone suppression test called a 1mg dexamethasone test, used to check for a mild condition where the adrenal gland produces slightly too much cortisol
- People who have a growth or abnormality on their adrenal gland that imaging scans suggest is a benign (non-cancerous) adrenal tumour or overgrowth of adrenal tissue
Who may not be able to join:
- People whose renin levels (a blood pressure hormone) are above the normal range before the suppression test is done
- People whose aldosterone levels (another blood pressure hormone) are below a certain low threshold before the suppression test
- People who show clear signs of having too much or too little of any adrenal hormone, beyond the mild cortisol condition being studied
- People who are currently taking corticosteroid medications, anti-inflammatory drugs (such as ibuprofen or similar), hormone replacement therapy, hormonal contraceptives, or who regularly consume liquorice
- People who have, or are suspected to have, high blood pressure caused by another underlying condition (other than excess aldosterone production)
- People with poorly managed diabetes or diabetes other than type 2, current or past alcohol misuse, severe obesity (a body mass index of 40 or above), serious heart or blood vessel disease that would prevent changes to long-term medication, an active cancer diagnosis, an autoimmune disease that is not well controlled or that has caused heart or kidney complications, significantly reduced kidney function (eGFR below 45), poor general physical health, or who have not given or have withdrawn their consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Piotr Kmiec, MD, Ph.D., Department of Endocrinology and Internal Medicine, Medical University of Gdansk
Phone: 0048 585844809
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall diagnostic accuracy of post-DXM ARR
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.